Focused Wealth Management, Inc Arrowhead Pharmaceuticals, Inc. Transaction History

Focused Wealth Management, Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	BUY	$27.79 - $50.61 $444 - $809	16 Added 88.89%	34 $1,000
Q1 2022 Apr 29, 2022	BUY	$39.62 - $69.97 $713 - $1,259	18 New	18 $1,000
Q4 2021 Jan 31, 2022	SELL	$58.09 - $82.51 $987 - $1,402	-17 Closed	0 $0
Q3 2021 Oct 12, 2021	BUY	$58.38 - $84.96 $116 - $169	2 Added 13.33%	17 $1,000
Q2 2021 Jul 15, 2021	BUY	$62.15 - $90.32 $932 - $1,354	15 New	15 $1,000

294

90.8M

155K

426K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.01B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Focused Wealth Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Focused Wealth Management, Inc with notifications on news.